Viropro Inc., a public company incorporated under the laws of the state of Nevada, specializes in the development of manufacturing processes for the production of generic biopharmaceutical drugs.  The manufacturing processes developed are out-licensed to various international partners who produce and distribute the final product. Viropro's revenues come from license fees from technology transfers and royalties from the sale of final product

The principal objective is to support pharmaceutical companies in South America, Asia, Africa and Eastern Europe by offering them the opportunity to locally produce and commercialize biotherapeutic products of industrial quality at an affordable price. Viropro enables emerging markets with unmet medical needs to gain access to biotherapeutics for the treatment of various diseases such as cancer, diabetes, chronic hepatitis, multiple sclerosis, and rhumatoid arthritis.